Author: Dominic

BREA, CALIF., March 31, 2020 — In response to the global COVID-19 pandemic, Beckman Coulter today announced that it is developing assays to identify IgM and IgG antibodies to the coronavirus or SARS-CoV-2. The assays will be designed for use on any of its high- throughput Access family of immunoassay systems, including the Access 2 and… Read more »

Beckman Coulter is strongly committed to the health and well-being of our associates, customers and partners, and we are fully supportive of the containment and virus management efforts that are being implemented by countries around the globe. During this time of uncertainty, we seek to bring clarity to some of the issues concerning our associates,… Read more »

Cruinn Diagnostics are to delighted to be providing Cepheid SARS-CoV-2 Tests to Laboratories around the country. Huge appreciation to our incredible front line HSE workers and the Laboratory Scientists going the extra mile every day. Click here to find out more  

Available Now! In response to the current COVID-19 global health emergency, our partners ZeptoMetrix™ Corporation and Microbiologics Inc have both announced the development and release of a SARS-CoV-2 quality control. Targeting both the N and E-gene, AB Scientific are supporting Hospitals in the UK and Ireland to provide safe options for intact, non-infectious QC materials…. Read more »

WHEN: MAY 19 – 20, 2020 Featuring thought leaders from around the globe, the digital pathology summit aims to showcase talks on the latest topics and advances in digital pathology whilst providing a collaborative and interactive experience in a virtual environment. This event is complimentary. Click here to sign up to the summit. FEATURED SPEAKERS:… Read more »

Accurate, complete, and timely reporting of notifiable infectious diseases is critical to identify outbreaks. The MedLIS project using Cerner Millennium will provide a single flexible platform for Ireland greatly enhancing the quality and efficiency of reporting on COVID & all infectious diseases into Public Health systems. Click here to find out more

https://www.cellpath.com/ In this article, CellPath introduce an aid to biopsy processing that protects tissue and facilitates production of maximum diagnostic information- the Lumea BxChip. We also share our conversation with an early adopter of the BxChip, and hear of the success they achieved with their trials. Needle core biopsies are taken to minimise patient discomfort… Read more »

Enhancing thrombotic thrombocytopenic purpura (TTP) diagnosis through quantifying ADAMTS-13 is time consuming and technically demanding.  However, a recent multi-centre evaluation of TECHNOSCREEN® ADAMTS13 activity assay as a screening tool for detecting deficiency of ADAMTS-13 has concluded that the test provides more rapid ADAMTS-13 level evaluation than most currently available assays.  “Its simple operation renders it suitable… Read more »

Cirdan is delighted to announce the award of a contract by Eurofins Pathology for a new generation Laboratory Information System (LIS). Eurofins Pathology is part of the wider Eurofins Scientific Group, a global leader in life sciences testing… Click here to find out more

As a result of the COVID-19 pandemic, laboratories across the world are being asked to rapidly scale up their testing capacity. In response to this we have been configuring our ULTRA Laboratory Information System (LIS) to facilitate this increased testing demand. Click here to find out more